1. Home
  2. TG vs DRUG Comparison

TG vs DRUG Comparison

Compare TG & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TG
  • DRUG
  • Stock Information
  • Founded
  • TG 1988
  • DRUG 2019
  • Country
  • TG United States
  • DRUG United States
  • Employees
  • TG N/A
  • DRUG N/A
  • Industry
  • TG Metal Fabrications
  • DRUG Pharmaceuticals and Biotechnology
  • Sector
  • TG Industrials
  • DRUG Health Care
  • Exchange
  • TG Nasdaq
  • DRUG Nasdaq
  • Market Cap
  • TG 271.9M
  • DRUG 260.6M
  • IPO Year
  • TG 1989
  • DRUG N/A
  • Fundamental
  • Price
  • TG $8.12
  • DRUG $35.99
  • Analyst Decision
  • TG
  • DRUG Strong Buy
  • Analyst Count
  • TG 0
  • DRUG 4
  • Target Price
  • TG N/A
  • DRUG $84.33
  • AVG Volume (30 Days)
  • TG 75.6K
  • DRUG 69.2K
  • Earning Date
  • TG 03-14-2025
  • DRUG 03-04-2025
  • Dividend Yield
  • TG N/A
  • DRUG N/A
  • EPS Growth
  • TG N/A
  • DRUG N/A
  • EPS
  • TG N/A
  • DRUG N/A
  • Revenue
  • TG $717,366,000.00
  • DRUG N/A
  • Revenue This Year
  • TG N/A
  • DRUG N/A
  • Revenue Next Year
  • TG N/A
  • DRUG N/A
  • P/E Ratio
  • TG N/A
  • DRUG N/A
  • Revenue Growth
  • TG N/A
  • DRUG N/A
  • 52 Week Low
  • TG $3.98
  • DRUG $0.93
  • 52 Week High
  • TG $9.22
  • DRUG $79.02
  • Technical
  • Relative Strength Index (RSI)
  • TG 57.93
  • DRUG 43.58
  • Support Level
  • TG $7.83
  • DRUG $40.10
  • Resistance Level
  • TG $8.34
  • DRUG $47.50
  • Average True Range (ATR)
  • TG 0.24
  • DRUG 3.56
  • MACD
  • TG 0.01
  • DRUG -0.51
  • Stochastic Oscillator
  • TG 66.91
  • DRUG 23.22

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: